Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Parkinson's disease and prostate enlargement: Both contribute to overactive bladder in the elderly.

Sakakibara R, Lee FC, Suzuki H, Tateno F, Kishi M, Aiba Y.

Int J Urol. 2018 Nov;25(11):982-983. doi: 10.1111/iju.13792. Epub 2018 Aug 28. No abstract available.

PMID:
30155980
2.

Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?

Lee KS, Lee HW, Han DH.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):491-501. doi: 10.1007/s00210-007-0242-y. Epub 2008 Jan 3. Review.

PMID:
18172610
3.

[Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB].

Sakakibara R.

Rinsho Shinkeigaku. 2013;53(11):1389-92. Review. Japanese.

PMID:
24292000
4.

A review of lower urinary tract symptoms in patients with Parkinson's disease.

Badri AV, Purohit RS, Skenazy J, Weiss JP, Blaivas JG.

Curr Urol Rep. 2014 Sep;15(9):435. doi: 10.1007/s11934-014-0435-0. Review.

PMID:
25002072
6.

Safety of anticholinergics in patients with benign prostatic hyperplasia.

Athanasopoulos A, Mitropoulos D, Giannitsas K, Perimenis P.

Expert Opin Drug Saf. 2008 Jul;7(4):473-9. doi: 10.1517/14740338.7.4.473 . Review.

PMID:
18613810
7.

Comparison of Silodosin and Naftopidil for Efficacy in the Treatment of Benign Prostatic Enlargement Complicated by Overactive Bladder: A Randomized, Prospective Study (SNIPER Study).

Matsukawa Y, Funahashi Y, Takai S, Majima T, Ogawa T, Narita H, Kato M, Gotoh M.

J Urol. 2017 Feb;197(2):452-458. doi: 10.1016/j.juro.2016.08.111. Epub 2016 Sep 8.

PMID:
27615436
8.

Treatment Patterns and Patient Reported Outcomes in Benign Prostatic Hyperplasia Patients with Overactive Bladder Symptoms.

Park YH, Kim TH, Lee SW, Chung BH, Cho JS, Lee JY.

Low Urin Tract Symptoms. 2017 May;9(2):75-81. doi: 10.1111/luts.12112. Epub 2015 Oct 9.

PMID:
28394492
10.
11.

Finger taps and constipation are closely related to symptoms of overactive bladder in male patients with Parkinson's disease.

Tsujimura A, Yamamoto Y, Sakoda S, Okuda H, Yamamoto K, Fukuhara S, Yoshioka I, Kiuchi H, Takao T, Miyagawa Y, Nonomura N.

Int J Urol. 2014 Jan;21(1):69-73. doi: 10.1111/iju.12186. Epub 2013 May 9.

12.

How to manage overactive bladder in elderly individuals with dementia? A combined use of donepezil, a central acetylcholinesterase inhibitor, and propiverine, a peripheral muscarine receptor antagonist.

Sakakibara R, Ogata T, Uchiyama T, Kishi M, Ogawa E, Isaka S, Yuasa J, Yamamoto T, Ito T, Yamanishi T, Awa Y, Yamaguchi C, Takahashi O.

J Am Geriatr Soc. 2009 Aug;57(8):1515-7. doi: 10.1111/j.1532-5415.2009.02369.x. No abstract available.

PMID:
19682155
13.

Improvement of Overactive Bladder Symptoms and Bladder Ischemia with Dutasteride in Patients with Benign Prostatic Enlargement.

Wada N, Matsumoto S, Kita M, Hashizume K, Kakizaki H.

Low Urin Tract Symptoms. 2015 Jan;7(1):37-41. doi: 10.1111/luts.12047. Epub 2014 Feb 24.

PMID:
26663650
14.

Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder.

Sugaya K, Nishijima S, Kadekawa K, Miyazato M, Mukouyama H.

Biomed Res. 2009 Oct;30(5):287-94.

15.

[The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].

Akino H, Maegawa M, Nagase K, Tanaka I, Nakai M, Ishida Y, Oyama N, Miwa Y, Yokoyama O.

Hinyokika Kiyo. 2008 Jun;54(6):449-52. Japanese.

16.

Are There Pharmacotherapeutic Options for Underactive Bladder?

Osman NI, Chapple CR.

Eur Urol Focus. 2018 Jan;4(1):6-7. doi: 10.1016/j.euf.2018.03.012.

PMID:
29776685
17.

Bladder function of patients with Parkinson's disease.

Sakakibara R, Tateno F, Nagao T, Yamamoto T, Uchiyama T, Yamanishi T, Yano M, Kishi M, Tsuyusaki Y, Aiba Y.

Int J Urol. 2014 Jul;21(7):638-46. doi: 10.1111/iju.12421. Epub 2014 Feb 27. Review.

18.

Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease.

Liu Z, Uchiyama T, Sakakibara R, Yamamoto T.

Int Urol Nephrol. 2015 May;47(5):751-7. doi: 10.1007/s11255-015-0951-y. Epub 2015 Mar 20.

PMID:
25792006
19.

Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease.

Kulaksizoglu H, Parman Y.

Parkinsonism Relat Disord. 2010 Sep;16(8):531-4. doi: 10.1016/j.parkreldis.2010.06.006. Epub 2010 Jul 15.

PMID:
20637678
20.

WITHDRAWN: Anticholinergics for urinary symptoms in multiple sclerosis.

Nicholas RS, Friede T, Hollis S, Young CA.

Cochrane Database Syst Rev. 2015 Jun 5;(6):CD004193. doi: 10.1002/14651858.CD004193.pub3. Review. No abstract available.

PMID:
26043867

Supplemental Content

Support Center